MedTrace Logo

A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT

NCT05613023 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1128

Last updated 2024-09-19

No results posted yet for this study

Summary

This study will compare the safety and efficacy of curative radiotherapy to the prostate and lymph glands given in 5 visits to that of prostate alone radiotherapy given in 5 visits, in men with high risk localised prostate cancer.

Conditions

Interventions

RADIATION

SBRT

Stereotactic Body Radiotherapy

Sponsors & Collaborators

  • Prostate Cancer UK

    collaborator OTHER

  • Institute of Cancer Research, United Kingdom

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-09
Primary Completion
2028-06-30
Completion
2030-06-30

Countries

  • Ireland
  • New Zealand
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05613023 on ClinicalTrials.gov